Clinical studies indicate that oral melatonin supplementation arrests periodontitis progression and alveolar bone destruction, evidenced by improved clinical parameters and reduced salivary RANKL/OPG ratio, regardless of the application of nonsurgical periodontal therapy [85]. Here, TNFSF11 is linked to periodontitis.